Australasian College of Dermatologists Meeting Abstracts

2019 Dermcoll , 52ND ANNUAL SCIENTIFIC MEETING

18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA

Abstract Number: 21

Safety of certolizumab pegol over 48 weeks in plaque psoriasis phase 3 trials

Abstract Number: 22

Identification of clinical and biomarker parameters associated with long-term maintenance of PASI 90 response following guselkumab treatment-withdrawal in psoriasis

Abstract Number: 23

Omalizumab for the treatment of acute urticarial drug eruption

Abstract Number: 24

Overcoming barriers to lifestyle modification in hidradenitis suppurativa

Abstract Number: 25

See and treat skin cancer clinic in dermatology – A single centre pilot study

Abstract Number: 26

Mycobacterium abscesses cutaneous infection during ustekinumab treatment in Crohn’s disease – A case report and review of literature

Abstract Number: 27

The hair clinic – What have we learned after 28 years?

Abstract Number: 28

Immunophenotyping of high risk head and neck SCC with imaging mass cytometry

Abstract Number: 29

Chronic unilateral suppurative cribriform ulcers in an elderly female

Abstract Number: 30

Immunohistochemical features of anti-PD1 induced lichenoid reactions in patients with metastatic melanoma with varied clinical responses